SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-009630
Filing Date
2024-03-12
Accepted
2024-03-12 07:30:41
Documents
15
Period of Report
2024-03-08
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43769
  Complete submission text file 0001493152-24-009630.txt   267529

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tcbp-20240308.xsd EX-101.SCH 4054
3 XBRL DEFINITION FILE tcbp-20240308_def.xml EX-101.DEF 27117
4 XBRL LABEL FILE tcbp-20240308_lab.xml EX-101.LAB 37499
5 XBRL PRESENTATION FILE tcbp-20240308_pre.xml EX-101.PRE 25737
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6855
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Filer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41231 | Film No.: 24740191
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)